On behalf of the organizing committee, we are pleased to invite you to the 14th International Congress on Lipid & Atherosclerosis (ICoLA 2025), hosted by the Korean Society of Lipid and Atherosclerosis (KSoLA), to be held on September 11 (Thu)–13 (Sat), 2025, at the Conrad Seoul, Republic of Korea.
Under the theme “Advancing Care in Lipids, Obesity, Glucose, and Blood Pressure: Exploring Innovative Therapies and Their Clinical Impact,” ICoLA 2025 expands its scientific vision beyond lipidology to encompass a comprehensive range of cardiometabolic risk factors. This broadened scope reflects our commitment to integrated strategies for the prevention and treatment of cardiovascular and metabolic diseases.
This year’s scientific program includes plenary and keynote lectures by global experts in lipid metabolism, vascular biology, and cardiometabolic disease management. These sessions will highlight recent advances in both basic science and clinical care, offering diverse perspectives from across the globe.
Further enhancing our global relevance, ICoLA 2025 will host joint symposia in collaboration with leading international societies, including the European Atherosclerosis Society (EAS), Japanese Atherosclerosis Society (JAS), and Canadian Society of Atherosclerosis, Thrombosis and Vascular Biology (CSATVB). These collaborative sessions will provide an exceptional opportunity to share scientific insights and foster global academic exchange.
In addition to plenary and keynote lectures, ICoLA 2025 will feature symposia, oral and poster presentations, and educational forums. Special emphasis will be placed on supporting young investigators, providing them with opportunities to present their work and engage with leaders in the field.
We warmly welcome your participation in ICoLA 2025. Join us in Seoul for an engaging and inspiring congress that promises to shape the future of cardiometabolic care.
Sincerely,
-
Ki Hoon Han
President, Board of Directors, KSoLA
-
Sang-Hyun Kim
Chairman, Board of Directors, KSoLA